ReShape Lifesciences, Inc.ReShape Lifesciences, Inc.ReShape Lifesciences, Inc.

ReShape Lifesciences, Inc.

No trades
See on Supercharts
Market capitalization
‪3.79 M‬USD
−3.7294USD
‪−11.39 M‬USD
‪8.68 M‬USD
‪20.81 M‬
Beta (1Y)
2.02

About ReShape Lifesciences, Inc.

CEO
Paul F. Hickey
Headquarters
San Clemente
Employees (FY)
31
Founded
2002
ISIN
US76090R2004
FIGI
BBG0036S6JY0
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RSLS is 0.16 USD — it has increased by 1.55% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ReShape Lifesciences, Inc. stocks are traded under the ticker RSLS.
ReShape Lifesciences, Inc. is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
RSLS earnings for the last quarter are −1.02 USD whereas the estimation was −1.20 USD which accounts for 15.00% surprise. Estimated earnings for the next quarter are −0.18 USD. See more details about ReShape Lifesciences, Inc. earnings.
ReShape Lifesciences, Inc. revenue for the last quarter amounts to ‪2.16 M‬ USD despite the estimated figure of ‪2.40 M‬ USD. In the next quarter revenue is expected to reach ‪2.21 M‬ USD.
Yes, you can track ReShape Lifesciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, RSLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ReShape Lifesciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RSLS reached its all-time high on Oct 6, 2016 with the price of 23820.00 USD, and its all-time low was 0.14 USD and was reached on Feb 14, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 31.00 employees. See our rating of the largest employees — is ReShape Lifesciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ReShape Lifesciences, Inc. EBITDA is ‪−14.48 M‬ USD, and current EBITDA margin is −166.92%. See more stats in ReShape Lifesciences, Inc. financial statements.